| 1 |
Aqueous Molecular Dynamics Simulations of the M-tuberculosis Enoyl-ACP Reductase-NADH System and Its Complex with a Substrate Mimic or Diphenyl Ethers Inhibitors
Lima CHD, de Alencastro RB, Kaiser CR, de Souza MVN, Rodrigues CR, Albuquerque MG
International Journal of Molecular Sciences, 16(10), 23695, 2015 |
| 2 |
Computer-Aided Design of Orally Bioavailable Pyrrolidine Carboxamide Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis with Favorable Pharmacokinetic Profiles
Kouassi AF, Kone M, Keita M, Esmel A, Megnassan E, N'Guessan YT, Frecer V, Miertus S
International Journal of Molecular Sciences, 16(12), 29744, 2015 |
| 3 |
Crystal structure of the enoyl-ACP reductase of Mycobacterium tuberculosis (InhA) in the apo-form and in complex with the active metabolite of isoniazid pre-formed by a biomimetic approach
Chollet A, Mourey L, Lherbet C, Delbot A, Julien S, Baltas M, Bernadou J, Pratviel G, Maveyraud L, Bernardes-Genisson V
Journal of Structural Biology, 190(3), 328, 2015 |
| 4 |
Combined effect of epigallocatechin gallate and triclosan on enoyl-ACP reductase of Mycobacterium tuberculosis
Sharma SK, Kumar G, Kapoor M, Surolia A
Biochemical and Biophysical Research Communications, 368(1), 12, 2008 |
| 5 |
Crystallographic studies on the binding of isonicotinyl-NAD adduct to wild-type and isoniazid resistant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis
Dias MVB, Vasconcelos IB, Prado AMX, Fadel V, Basso LA, De Azevedo WF, Santos DS
Journal of Structural Biology, 159(3), 369, 2007 |
| 6 |
Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid
Mdluli K, Slayden RA, Zhu YQ, Ramaswamy S, Pan X, Mead D, Crane DD, Musser JM, Barry CE
Science, 280(5369), 1607, 1998 |
| 7 |
The Requirement for Manganese and Oxygen in the Isoniazid-Dependent Inactivation of Mycobacterium-Tuberculosis Enoyl Reductase
Zabinski RF, Blanchard JS
Journal of the American Chemical Society, 119(9), 2331, 1997 |
